[Pharmacodynamic studies of pentaerythritol di (para methylbenzeneboronate)].
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D000927:Anticonvulsants / Q000494:pharmacology*; D001897:Boronic Acids / Q000494:pharmacology*; D002319:Cardiovascular System / Q000187:drug effects*; D002490:Central Nervous System / Q000187:drug effects*; D004285:Dogs; D004357:Drug Synergism; D005260:Female; D006018:Glycols / Q000494:pharmacology*; D006168:Guinea Pigs; D066298:In Vitro Techniques; D008297:Male; D051379:Mice; D011817:Rabbits; D051381:Rats; D012119:Respiration / Q000187:drug effects*; D014665:Vasodilator Agents / Q000494:pharmacology*
D000889:Anti-Arrhythmia Agents; D000927:Anticonvulsants; D001897:Boronic Acids; D006018:Glycols; D014665:Vasodilator Agents
Recherches pharmacodynamiques sur le di (p. méthylbenzeneboronate) de pentaerythritol.